Skip to main content

Table 3 Intervention for patients with declining ALSFRS-R

From: How COVID-19 pandemic changed our management strategies for amyotrophic lateral sclerosis (ALS) patients: Egyptian study

Bulbar ALS 62.5%
Gastrostomy 3/8 (37.5%)
Botox injection 2/8 (25%)
NIV 8/8 (100%)
  1. NIV non-invasive ventilation